Lymphadenopathy screening: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Xyz}} {{CMG}}; {{AE}} ==Overview== There is insufficient evidence to recommend routine screening for [disease/malignancy]. OR According to the [guideline nam..." |
No edit summary |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{Lymphadenopathy}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{ADS}} [[Ogechukwu Hannah Nnabude, MD]] | ||
==Overview== | ==Overview== | ||
There is insufficient evidence to recommend routine screening for | There is insufficient evidence to recommend routine screening for lymphadenopathy | ||
==Screening== | ==Screening== | ||
There is insufficient evidence to recommend routine screening for | *There is insufficient evidence to recommend routine screening for lymphadenopathy | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
| |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Medicine]] | |||
[[Category:Oncology]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Surgery]] | |||
Latest revision as of 05:17, 9 December 2021
|
Lymphadenopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Lymphadenopathy screening On the Web |
|
American Roentgen Ray Society Images of Lymphadenopathy screening |
|
Risk calculators and risk factors for Lymphadenopathy screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2] Ogechukwu Hannah Nnabude, MD
Overview
There is insufficient evidence to recommend routine screening for lymphadenopathy
Screening
- There is insufficient evidence to recommend routine screening for lymphadenopathy